FORSCHUNGSZENTRUM BORSTEL has a total of 16 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1999. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Germany. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are SMITHKLINE BEECHAM BIOLOGICALS SA, CHIRON SPA and ROSALIND FRANKLIN UNIVERSITY O.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Germany | 2 | |
#4 | Australia | 1 | |
#5 | China | 1 | |
#6 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Machines | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Roeckendorf Niels | 4 |
#2 | Gorris Hans-Heiner | 4 |
#3 | Frey Andreas | 4 |
#4 | Bade Steffen | 4 |
#5 | Gerdes Johannes | 3 |
#6 | Wohlenberg Claudia | 3 |
#7 | Scholzen Thomas | 3 |
#8 | Scheufele Swetlana | 2 |
#9 | Ammerpohl Ole | 2 |
#10 | Baron-Luhr Bettina | 2 |
Publication | Filing date | Title |
---|---|---|
EP3789505A1 | Methods and means for diagnosing lung cancer | |
DE102018003770A1 | Nanocontainers for the transport of nonpolar, lipophilic substances such as antibiotics | |
ZA201702925B | New immunostimulatory compounds | |
EP2311457A1 | Pharmaceutical compositions for treating infections with drug resistant mycobacteria | |
DE19915057A1 | Monoclonal antibodies to the human Mcm3 protein, process for their preparation and their use | |
AU4130199A | Processive glycosyltransferase |